![](/img/cover-not-exists.png)
Should all patients with immuneâmediated thrombotic thrombocytopenic purpura receive caplacizumab?
Picod, Adrien, Veyradier, Agnès, Coppo, PaulJournal:
Journal of Thrombosis and Haemostasis
DOI:
10.1111/jth.15194
Date:
November, 2020
File:
PDF, 10.75 MB
2020